Fact.MR forecasts bullish prospects for the plasma fractionation market. The utilization of immunoglobulins has augmented in the last few years. Plasma-derived immunoglobulins are giving a new narrative to healthcare across a wide range of autoimmune and inflammatory diseases. This widespread
source https://www.openpr.com/news/2303810/demand-for-plasma-fractionation-market-to-grow-1-5x-through-2026